Sohini Das, Business Standard

Stories by Sohini Das, Business Standard

Govt may now cap prices of antibiotics

Govt may now cap prices of antibiotics

Rediff.com   7 Oct 2019

The intention of the government is to cap prices of drugs that are essential and which the public widely uses.

DRL, 1st Indian company to supply generic drugs to China's state hospitals

DRL, 1st Indian company to supply generic drugs to China's state hospitals

Rediff.com   27 Sep 2019

The drug that it would supply is called Olanzapine, used to treat schizophrenia and bipolar disorder.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com   26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

Company performance vs CEO salary: Explained in 6 charts

Company performance vs CEO salary: Explained in 6 charts

Rediff.com   19 Sep 2019

Mid and small companies are more generous in rewarding their CEOs as compared to their larger peers.

Drones will deliver critical drugs at your doorstep

Drones will deliver critical drugs at your doorstep

Rediff.com   17 Sep 2019

Maharashtra govt, California-based Zipline to launch the automated delivery service funded by Serum Institute.

Airtel beats Vodafone Idea to become India's No 2 telco

Airtel beats Vodafone Idea to become India's No 2 telco

Rediff.com   6 Aug 2019

What worked for Airtel was that its data traffic growth was 13 per cent sequentially and its average data usage was even higher than Jio's at 11.9 gigabyte per month per user.

Why JioPhone is no more popular in Bharat

Why JioPhone is no more popular in Bharat

Rediff.com   5 Aug 2019

Used smartphones are gaining popularity in the hinterland, the main market for JioPhone. Share of JioPhone in the feature phone market had shrunk from 47% in Q2 of 2018 to 28% a year after.

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Rediff.com   2 Aug 2019

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore.

India's rural mobile phone base slips further

India's rural mobile phone base slips further

Rediff.com   26 Jun 2019

According to telcos and analysts, this is due to SIM consolidation happening after the minimum recharge plans were implemented by incumbents.

Despite cap on pricing import of medical devices rises

Despite cap on pricing import of medical devices rises

Rediff.com   24 Jun 2019

The growth in imports was led by product categories such as diagnostic items, ultra-sonogram machines, MRI and ECG apparatus, syringes with needles, suture needles, digital thermometers, malaria diagnostic kits, and hearing aids.

Why telcos have little interest in 5G auctions

Why telcos have little interest in 5G auctions

Rediff.com   17 Jun 2019

Bharti Airtel called the prices exorbitant while Vodafone Idea wants the auctions take place in 2020. The auctions need to happen when the infrastructure is ready for the roll out, be it in terms of fiberisation levels, or optimisation of equipment and software etc. Spending a hefty amount on a technology (airwaves) that at present offers limited returns is not going to be a priority for the incumbent telcos.

'Credit, liquidity should top agenda of Modi 2.0'

'Credit, liquidity should top agenda of Modi 2.0'

Rediff.com   24 May 2019

'We all wanted a strong Centre with a decisive mandate from the people, to allow them to take bold decisions.'

What Modi2 needs to do

What Modi2 needs to do

Rediff.com   24 May 2019

The new government's challenge would be to reverse the tide in FDI, boost manufacturing and come up with an e-commerce policy that is fair to all investors.

Mobile user base suffers biggest fall since April 2018

Mobile user base suffers biggest fall since April 2018

Rediff.com   22 May 2019

Mukesh Ambani's Reliance Jio, however, continued to add wireless subscribers

2 reasons why drug sales are in poor health

2 reasons why drug sales are in poor health

Rediff.com   11 May 2019

Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.

How Saridon has managed to remain top of the mind

How Saridon has managed to remain top of the mind

Rediff.com   3 May 2019

What has worked though for Brand Saridon has been its single-minded focus on headaches as opposed to other analgesics that dwell on a wider set of problems, reports Sohini Das.

Right time to invest in small-cap funds?

Right time to invest in small-cap funds?

Rediff.com   30 Apr 2019

Exposure to these funds should not exceed 10% to 15% of the equity portfolio and the investment horizon should be at least seven years.

Can Vodafone Idea reap synergy benefits?

Can Vodafone Idea reap synergy benefits?

Rediff.com   23 Apr 2019

India's largest telecom operator in terms of subscriber numbers has been struggling to raise its share of subscribers in the market for fourth-generation technology services.

MNC pharma cos may be afflicted by pneumonia virus

MNC pharma cos may be afflicted by pneumonia virus

Rediff.com   22 Apr 2019

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.

Why Jio may now have to buy spectrum from the open market

Why Jio may now have to buy spectrum from the open market

Rediff.com   20 Apr 2019

While the company insisted it had enough spectrum across circles, analysts said the company might soon need to acquire some spectrum to ensure uninterrupted service.